To analyze efficacy and safety of pegfilgrastim versus filgrastim in patients with breast cancer.

e20587 Background: We evaluated the safety and efficacy of a single fixed 6 mg dose of pegfilgrastim (a pegylated version of filgrastim) per cycle of chemotherapy, compared with daily administration of filgrastim, in the provision of neutrophil support. METHODS Patients with carcinoma of breast, less than 65 yrs with ECOG performance status 0 or 1 treated… CONTINUE READING